2BB score and signals
Compass Therapeutics, Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 19 | Very Weak |
| Quality | 60 | Strong |
| Risk | 10 | Very Low |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2014 |
| Employees | 39 |
| 52-week range | $1.61 – $6.88 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | -0.1217 | — | $0.00 |
| 2026-08-05 | — | -0.1105 | — | $0.00 |
| 2026-05-06 | — | -0.1 | — | $0.00 |
| 2026-02-27 | — | -0.0963 | — | $0.00 |
2BBBullish & Bearish